Table 1. Demographic and clinical characteristics of patients (n=50).
n | % | Median | Min-Max | IQR | |
---|---|---|---|---|---|
Age (year) | 50.5 | 27-68 | 17 | ||
Body mass index (kg/m2) | 27.1 | 19.3-36.6 | 5.3 | ||
Disease duration (month) | 60 | 1-444 | 84 | ||
Disease activity score-28 | 2.7 | 1.4-5.7 | 1.5 | ||
Tender joint count | 0 | 0-10 | 2 | ||
Swollen joint count | 0 | 0-10 | 0.3 | ||
Erythrocyte sedimentation rate | 22 | 5-68 | 18.5 | ||
C-reactive protein | 3 | 0-30 | 4 | ||
Clinical type | |||||
Asymmetric oligoarthritis | 33 | 66 | |||
Symmetric polyarthritis | 11 | 22 | |||
Axial disease predominant | 6 | 12 | |||
Active psoriasis | 31 | 62 | |||
Dactylitis | 5 | 10 | |||
Active arthritis | 11 | 22 | |||
Treatment | |||||
csDMARDs | 32 | 64 | |||
csDMARDs + steroids | 5 | 10 | |||
bDMARDs | 13 | 26 | |||
Min: Minimum; Max: Maximum; IQR: Interquartile range; csDMARDs: Conventional synthetic disease-modifying antirheumatic drugs; bDMARDs: Biological disease-modifying antirheumatic drugs. |